tiprankstipranks
Outlook Therapeutics (OTLK)
NASDAQ:OTLK
US Market
OTLK
Outlook Therapeutics
RESEARCH TOOLSreports
Want to see OTLK full AI Analyst Report?

Outlook Therapeutics (OTLK) Income Statement

1,596 Followers

Outlook Therapeutics Income Statement

Last quarter (Q1 2026), Outlook Therapeutics's total revenue was $-1.21M, a decrease of -Infinity% from the same quarter last year. In Q1, Outlook Therapeutics's net income was $-23.06M. See Outlook Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22Sep 21
Total Revenue
$ 1.41M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 657.21K$ -113.86K$ -44.19K$ -204.69K$ -262.14K
Operating Expenses
$ 67.72M$ 71.70M$ 53.13M$ 62.87M$ 51.73M
Depreciation and Amortization
$ 117.05K$ 113.86K$ 44.19K$ 204.69K$ 262.14K
EBITDA
$ -63.58M$ -72.09M$ -57.38M$ -64.36M$ -51.51M
Operating Income
$ -67.06M$ -71.70M$ -53.13M$ -63.07M$ -51.73M
Other Income/Expenses
$ 3.08M$ -3.66M$ -5.85M$ -2.98M$ -1.43M
Pretax Income
$ -63.98M$ -75.36M$ -58.98M$ -66.05M$ -53.16M
Net Income
$ -62.42M$ -75.37M$ -58.98M$ -66.05M$ -53.16M
Per Share Metrics
Basic EPS
$ -1.79$ -4.06$ -4.72$ -6.23$ -6.96
Diluted EPS
$ -1.79$ -4.06$ -4.72$ -6.23$ -6.96
Weighted Average Shares Outstanding
 34.80M 18.55M 12.51M 10.60M 7.63M
Weighted Average Shares Outstanding (Diluted)
 25.48M 18.55M 12.51M 10.60M 7.63M
Currency in USD

Outlook Therapeutics Earnings and Revenue History